AVTX · Insider trading · 13F holders · Congress trades
Avalo Therapeutics, Inc. (AVTX)
Who is buying and selling AVTX: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 28
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $1.9M
- Congress trades, 12 months
- 0
AVTX at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 3 AVTX insiders filed 7 sales worth $1.9M on SEC Form 4, and no open-market purchases; 6 of the sales were pre-planned under Rule 10b5-1.
- 28 13F filers hold AVTX among their 50 largest positions, worth $619.6M combined, including Behzad Aghazadeh. The biggest bets by portfolio weight are Velan Capital Investment Management LP (3.7%), Ally Bridge Group (NY) LLC (3.6%) and Caligan Partners LP (2.8%). In their latest 13Fs, 6 managers opened a new position and 12 added to one.
- No member of Congress has disclosed a trade in AVTX.
- AVTX last closed at $7.44 on Oct 29, 2026.
AVTX insider trading
Between Aug 1, 2026 and Oct 29, 2026, 3 AVTX insiders filed 7 sales worth $1.9M on SEC Form 4, and no open-market purchases; 6 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sale10b5-1 | 12,394 | $16.33 | $202K | SEC |
| Sep 11, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sale10b5-1 | 10,185 | $17.62 | $179K | SEC |
| Sep 1, 2026 | Doyle Mittie | Chief Medical Officer | Sale10b5-1 | 679 | $20.00 | $14K | SEC |
| Aug 19, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sale10b5-1 | 72,725 | $19.94 | $1.5M | SEC |
| Aug 19, 2026 | Doyle Mittie | Chief Medical Officer | Sale10b5-1 | 1,000 | $20.00 | $20K | SEC |
| Aug 12, 2026 | Riley Jennifer | Chief Strategy Officer | Sale | 2,655 | $19.59 | $52K | SEC |
| Aug 12, 2026 | Doyle Mittie | Chief Medical Officer | Sale10b5-1 | 679 | $20.00 | $14K | SEC |
Who owns AVTX? Hedge funds and superinvestors
28 13F filers hold AVTX among their 50 largest positions, worth $619.6M combined, including Behzad Aghazadeh. The biggest bets by portfolio weight are Velan Capital Investment Management LP (3.7%), Ally Bridge Group (NY) LLC (3.6%) and Caligan Partners LP (2.8%). In their latest 13Fs, 6 managers opened a new position and 12 added to one.
Superinvestors holding AVTX: Behzad Aghazadeh 0.4%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Deep Track Capital, LPHedge fund | 1.0% | $66.7M | 3,610,000 | — | Q2 2026 |
| Caligan Partners LPHedge fund | 2.8% | $58.5M | 3,163,866 | +93.5% shares | Q2 2026 |
| TCG Crossover Management, LLCHedge fund | 1.3% | $55.8M | 3,017,120 | +308.6% shares | Q2 2026 |
| Affinity Asset Advisors, LLCHedge fund | 2.7% | $53.6M | 2,900,000 | +116.3% shares | Q2 2026 |
| Farallon Capital Management, L.l.c.Hedge fund | 0.3% | $46.2M | 2,498,000 | — | Q2 2026 |
| Behzad AghazadehHedge fund | 0.4% | $43.1M | 2,333,333 | +65.5% shares | Q2 2026 |
| Bvf Inc/ilInvestment manager | 1.0% | $38.4M | 2,075,545 | +27.1% shares | Q2 2026 |
| Nantahala Capital Management, LLCHedge fund | 2.1% | $34.4M | 1,862,250 | +50.8% shares | Q2 2026 |
| Soleus Capital Management, L.P.Hedge fund | 1.1% | $30.6M | 1,654,978 | — | Q2 2026 |
| Braidwell LPHedge fund | 1.2% | $30.1M | 1,629,182 | — | Q2 2026 |
| Logos Global Management LPHedge fund | 0.9% | $21.3M | 1,150,000 | — | Q2 2026 |
| Commodore Capital LPHedge fund | 1.1% | $18.8M | 1,018,319 | +110.8% shares | Q2 2026 |
| Trails Edge Capital Partners, LPHedge fund | 2.6% | $16.5M | 891,881 | New | Q2 2026 |
| Vestal Point Capital, LPHedge fund | 0.3% | $14.3M | 775,000 | — | Q2 2026 |
| Seven Fleet Capital Management LPHedge fund | 2.4% | $14.2M | 770,765 | +260.5% shares | Q2 2026 |
| Parkman Healthcare Partners LLCHedge fund | 1.5% | $14.2M | 766,290 | — | Q2 2026 |
| Silverarc Capital Management, LLCHedge fund | 1.0% | $9.2M | 500,402 | — | Q2 2026 |
| Davern Capital Partners, LPInstitutional asset manager | 1.5% | $8.7M | 468,666 | New | Q2 2026 |
| Pivotal bioVenture Partners Investment Advisor LLCVenture capital | 2.6% | $8.0M | 434,033 | +46.7% shares | Q2 2026 |
| Boxer Capital Management, LLCHedge fund | 0.5% | $6.9M | 375,000 | +25.0% shares | Q2 2026 |
| Dv Equities, LLCInvestment manager | 0.9% | $6.1M | 332,213 | — | Q2 2026 |
| Velan Capital Investment Management LPHedge fund | 3.7% | $6.0M | 324,452 | +75.3% shares | Q2 2026 |
| Vivo Capital, LLCHedge fund | 0.5% | $5.1M | 275,000 | New | Q2 2026 |
| Eagle Health Investments LPHedge fund | 0.7% | $4.3M | 235,093 | New | Q2 2026 |
| Acuta Capital Partners, LLCHedge fund | 2.4% | $3.4M | 186,308 | +206.4% shares | Q2 2026 |
| Ally Bridge Group (NY) LLCHedge fund | 3.6% | $2.8M | 150,000 | New | Q2 2026 |
| Sectoral Asset Management IncHedge fund | 1.5% | $2.2M | 119,923 | — | Q2 2026 |
| Lynx1 Capital Management LPHedge fund | 0.0% | $187K | 10,100 | New | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 28). Screen AVTX in the grand portfolio →
AVTX stock trades by members of Congress
No member of Congress has disclosed a trade in AVTX.
Analysis mentioning AVTX
Posts from the blog that cover Avalo Therapeutics, Inc., newest first.
AVTX questions and answers
Are insiders buying AVTX stock?
Between Aug 1, 2026 and Oct 29, 2026, 3 AVTX insiders filed 7 sales worth $1.9M on SEC Form 4, and no open-market purchases; 6 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own AVTX?
28 13F filers hold AVTX among their 50 largest positions, worth $619.6M combined, including Behzad Aghazadeh. The biggest bets by portfolio weight are Velan Capital Investment Management LP (3.7%), Ally Bridge Group (NY) LLC (3.6%) and Caligan Partners LP (2.8%). In their latest 13Fs, 6 managers opened a new position and 12 added to one.
Has Congress traded AVTX?
No member of Congress has disclosed a trade in AVTX.
Who is the largest holder of AVTX?
Among 13F filers, Deep Track Capital, LP reports the largest AVTX position, $66.7M (3,610,000 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Velan Capital Investment Management LP's: 3.7% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.